To test the efficiency of air dis-infection of the Novaerus devices on bacteria.
19 NV800 devices and 4 NV200 devices were installed in the Pulmonology Department, covering 30 beds in 7 wards and connected high/medium risk areas.
8 NV800 devices were installed in the Traumatology, Septic Department, covering 12 beds in 4 wards and connected high risk areas.
T0 background contamination samples were taken before installation of the Novaerus devices. T4 efficiency test samples were taking after 2 months operation of the Novaerus devices.
Testing reflected an 82% drop in CFU rates and a 93% reduction in fungi count. The air quality now meets the Swiss Class III standard (500 CFU/m3 for general wards).
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma nanotechnology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.